Objectives: 

1.   Review the 2013 ACC/AHA lipid management guidelines

2.   Understand how to calculate cardiovascular risk for primary prevention

3.   Explain the rationale for drug therapy for hyperlipidemia

 

Session date: 
Tuesday, September 13, 2016 - 8:30am to 9:30am
Speaker Name: 
Matthew Sorrentino, M.D.
Location: 
UCMC N-002
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.